Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000527.5(LDLR):c.727T>C (p.Cys243Arg)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA10585105

251425 (ClinVar)

Gene: LDLR

Condition: hypercholesterolemia, familial

Inheritance Mode: Semidominant inheritance

Link to MONDO

UUID: 9e2e98d3-6ac1-41d2-826f-87825e2b6139

Approved on: 2023-04-28

Published on: 2023-05-01

HGVS expressions

NM_000527.5:c.727T>C

NM_000527.5(LDLR):c.727T>C (p.Cys243Arg)

NC_000019.10:g.11106597T>C

CM000681.2:g.11106597T>C

NC_000019.9:g.11217273T>C

CM000681.1:g.11217273T>C

NC_000019.8:g.11078273T>C

NG_009060.1:g.22217T>C

ENST00000558518.6:c.727T>C

ENST00000252444.9:n.981T>C

ENST00000455727.6:c.314-795T>C

ENST00000535915.5:c.604T>C

ENST00000545707.5:c.346T>C

ENST00000557933.5:c.727T>C

ENST00000558013.5:c.727T>C

ENST00000558518.5:c.727T>C

ENST00000558528.1:n.242T>C

ENST00000560467.1:n.327T>C

NM_000527.4:c.727T>C

NM_001195798.1:c.727T>C

NM_001195799.1:c.604T>C

NM_001195800.1:c.314-795T>C

NM_001195803.1:c.346T>C

NM_001195798.2:c.727T>C

NM_001195799.2:c.604T>C

NM_001195800.2:c.314-795T>C

NM_001195803.2:c.346T>C

Likely Pathogenic

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Insufficient Evidence"

PP4 PP3 PM1 PM2 PS4_Supporting

Evidence Links 0

Expert Panel

Familial Hypercholesterolemia VCEP

Criteria Specification Information

Criteria Specification: ClinGen Familial Hypercholesterolemia Expert Panel Specifications to the ACMG/AMP Variant Classification Guidelines Version 1.2

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Familial Hypercholesterolemia VCEP

The NM_000527.5(LDLR):c.727T>C (p.Cys243Arg) variant is classified as likely pathogenic for Familial Hypercholesterolemia by applying evidence code PM1, PM2, PP3, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows: PM2 - This variant is absent from gnomAD (gnomAD v2.1.1). PP3 - REVEL = 0.966 PM1 - Variant meets PM2 and alters Cys243, one of the cysteine residues listed. PS4_Supporting - Variant meets PM2 and is identified in 2 index cases who fullfill DLCN≥6 criteria for FH from Research Lab of Molecular Genetics of Lipid Metabolism and PMID: 28502510. PP4 - Variant meets PM2 and is identified in 2 index cases who fullfill DLCN≥6 criteria for FH from Research Lab of Molecular Genetics of Lipid Metabolism after alternative cause of high cholesterol were excluded.

PP4

Variant meets PM2 and is identified in 2 index cases who fullfill DLCN≥6 criteria for FH from Research Lab of Molecular Genetics of Lipid Metabolism after alternative cause of high cholesterol were excluded.

PP3

REVEL = 0.966

PM1

Variant meets PM2 and alters Cys243, one of the cysteine residues listed.

PM2

This variant is absent from gnomAD (gnomAD v2.1.1).

PS4_Supporting

Variant meets PM2 and is identified in 2 index cases who fullfill DLCN≥6 criteria for FH from Research Lab of Molecular Genetics of Lipid Metabolism and PMID: 28502510.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.